PT2959892T - Comprimido com revestimento entérico - Google Patents

Comprimido com revestimento entérico

Info

Publication number
PT2959892T
PT2959892T PT147549752T PT14754975T PT2959892T PT 2959892 T PT2959892 T PT 2959892T PT 147549752 T PT147549752 T PT 147549752T PT 14754975 T PT14754975 T PT 14754975T PT 2959892 T PT2959892 T PT 2959892T
Authority
PT
Portugal
Prior art keywords
coated tablet
enteric coated
enteric
tablet
coated
Prior art date
Application number
PT147549752T
Other languages
English (en)
Original Assignee
Zeria Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51391349&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2959892(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zeria Pharm Co Ltd filed Critical Zeria Pharm Co Ltd
Publication of PT2959892T publication Critical patent/PT2959892T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/606Salicylic acid; Derivatives thereof having amino groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT147549752T 2013-02-22 2014-02-21 Comprimido com revestimento entérico PT2959892T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013032759 2013-02-22

Publications (1)

Publication Number Publication Date
PT2959892T true PT2959892T (pt) 2020-12-15

Family

ID=51391349

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147549752T PT2959892T (pt) 2013-02-22 2014-02-21 Comprimido com revestimento entérico

Country Status (25)

Country Link
US (4) US20150374632A1 (pt)
EP (1) EP2959892B1 (pt)
JP (1) JP6237760B2 (pt)
KR (1) KR102167265B1 (pt)
CN (1) CN105025888B (pt)
AU (1) AU2014219726B2 (pt)
BR (1) BR112015020237B1 (pt)
CA (1) CA2901166C (pt)
CY (1) CY1123908T1 (pt)
DK (1) DK2959892T3 (pt)
ES (1) ES2821766T3 (pt)
HR (1) HRP20201808T1 (pt)
HU (1) HUE052167T2 (pt)
IL (1) IL240575B (pt)
LT (1) LT2959892T (pt)
MX (1) MX369967B (pt)
NZ (1) NZ711201A (pt)
PT (1) PT2959892T (pt)
RS (1) RS61099B1 (pt)
RU (1) RU2675844C2 (pt)
SG (1) SG11201506653WA (pt)
SI (1) SI2959892T1 (pt)
TW (1) TWI688411B (pt)
WO (1) WO2014129568A1 (pt)
ZA (1) ZA201506585B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2990578C (en) 2015-06-30 2023-09-26 National University Corporation Okayama University Drug for preventing or treating inflammatory bowel disease
EP3162362A1 (de) * 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Optimierte mesalazinhaltige hochdosistablette
CN106511277A (zh) * 2016-11-22 2017-03-22 吉林省博大伟业制药有限公司 一种聚普瑞锌颗粒剂及其制备方法
US10098898B1 (en) 2017-12-04 2018-10-16 Handa Pharmaceuticals, Llc Release stable mesalamine dosage forms
EP3662898A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Solid composition comprising mesalazine

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58109413A (ja) * 1981-12-23 1983-06-29 Eisai Co Ltd 耐衝撃性腸溶錠
US5914132A (en) 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
ITMI991316A1 (it) * 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
US20020028240A1 (en) * 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
MXPA04004747A (es) * 2001-11-23 2004-08-02 Procter & Gamble Forma de dosificacion farmaceutica con multiples recubrimientos.
ES2645930T3 (es) * 2003-01-03 2017-12-11 Supernus Pharmaceuticals, Inc. Utilización de una mezcla de dos o más materiales entéricos para regular la liberación de fármacos a través de una membrana o matriz para terapias sistémicas
US20050042277A1 (en) * 2003-07-17 2005-02-24 Irukulla Srinivas Pharmaceutical compositions having a swellable coating
MY147202A (en) 2003-11-26 2012-11-14 Novartis Ag Compositions comprising organic compounds
DE102006035549A1 (de) * 2006-07-27 2008-01-31 Evonik Röhm Gmbh Arzneiform mit mindestens zweischichtiger Trennschicht
SI2152250T1 (sl) * 2007-05-07 2020-06-30 Evonik Operations Gmbh Trdne dozirne oblike, ki vsebujejo enterično oplaščenje s pospešenim sproščanjem zdravila
JP2011500553A (ja) * 2007-10-10 2011-01-06 ルピン・リミテッド 5−アミノサリチル酸またはその塩もしくは代謝産物の新規な結腸を標的とする調節放出性生体接着性製剤
US20090162434A1 (en) * 2007-12-21 2009-06-25 Disphar International Bv Mesalazine tablet
US8329208B2 (en) * 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
CN101732280B (zh) * 2009-10-23 2012-04-18 天津力生制药股份有限公司 一种结肠定位释药的口服制剂
EP2425826A1 (en) * 2010-09-01 2012-03-07 Disphar International B.V. Mesalazine tablet having improved dissolution
EP2468264A1 (en) * 2010-12-27 2012-06-27 Laboratorios Liconsa, S.A. Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it
EP3187171A1 (en) * 2012-04-30 2017-07-05 Tillotts Pharma AG A delayed release drug formulation

Also Published As

Publication number Publication date
SG11201506653WA (en) 2015-09-29
KR20150118160A (ko) 2015-10-21
US20150374632A1 (en) 2015-12-31
IL240575A0 (en) 2015-09-24
EP2959892A4 (en) 2016-10-05
SI2959892T1 (sl) 2020-12-31
IL240575B (en) 2020-07-30
EP2959892B1 (en) 2020-09-09
EP2959892A1 (en) 2015-12-30
CA2901166A1 (en) 2014-08-28
BR112015020237B1 (pt) 2022-09-13
RU2015140119A3 (pt) 2018-03-06
AU2014219726B2 (en) 2018-03-15
JP6237760B2 (ja) 2017-11-29
JPWO2014129568A1 (ja) 2017-02-02
TWI688411B (zh) 2020-03-21
CN105025888A (zh) 2015-11-04
CA2901166C (en) 2020-03-24
HRP20201808T1 (hr) 2021-01-08
ES2821766T3 (es) 2021-04-27
ZA201506585B (en) 2017-03-29
CN105025888B (zh) 2018-10-12
WO2014129568A1 (ja) 2014-08-28
US20210093577A1 (en) 2021-04-01
LT2959892T (lt) 2020-12-10
AU2014219726A1 (en) 2015-09-10
KR102167265B1 (ko) 2020-10-19
HUE052167T2 (hu) 2021-04-28
CY1123908T1 (el) 2022-03-24
RS61099B1 (sr) 2020-12-31
US20230372250A1 (en) 2023-11-23
RU2675844C2 (ru) 2018-12-25
DK2959892T3 (da) 2020-09-21
US20190015345A1 (en) 2019-01-17
RU2015140119A (ru) 2017-03-30
MX369967B (es) 2019-11-27
TW201501731A (zh) 2015-01-16
BR112015020237A2 (pt) 2017-07-18
MX2015010871A (es) 2015-12-01
NZ711201A (en) 2019-10-25

Similar Documents

Publication Publication Date Title
GB201306312D0 (en) Tablet case
HK1219427A1 (zh) 複合物
HK1217316A1 (zh) 可光配向的物體
ZA201506585B (en) Enteric coated tablet
PL3033205T3 (pl) Agregat powlekający
HUE053605T2 (hu) Ferde sztent
IL241350A0 (en) Subprevir tablets
HK1205463A1 (zh) 含有 -羥基- -咪唑- -甲酰胺的片劑
SI3046548T1 (sl) Tableta, ki vsebuje krospovidon
GB201305361D0 (en) Enhanced expression
EP2971689A4 (en) CONFIGURATION WITH MULTIPLE COATINGS
HK1224197A1 (zh) 度洛西汀腸溶包衣片劑
PL2833346T3 (pl) Przedmiot powleczony
GB201311332D0 (en) Grease-repellent coating
GB201311531D0 (en) Concept six
GB201311548D0 (en) Concept four
HU4589U (en) Capsule
AU355585S (en) A coat
GB201317353D0 (en) Ed
GB201311537D0 (en) Concept sixteen
GB201311463D0 (en) Concept Nine
GB201311534D0 (en) Concept fifteen